Display Settings:

Format

Send to:

Choose Destination

    Biochem Biophys Res Commun. 2002 Oct 18;298(1):116-20.

    Novel mutations in sarcomeric protein genes in dilated cardiomyopathy.

    Daehmlow S, Erdmann J, Knueppel T, Gille C, Froemmel C, Hummel M, Hetzer R, Regitz-Zagrosek V.

    Department of Cardiac and Thoracic Surgery, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, D-13353, Berlin, Germany.

    Mutations in sarcomeric protein genes have been reported to cause dilated cardiomyopathy (DCM). In order to detect novel mutations we screened the sarcomeric protein genes beta-myosin heavy chain (MYH7), myosin-binding protein C (MYBPC3), troponin T (TNNT2), and alpha-tropomyosin (TPM1) in 46 young patients with DCM. Mutation screening was done using single-strand conformation polymorphism (SSCP) analysis and DNA sequencing. The mutations in MYH7 were projected onto the protein data bank-structure (pdb) of myosin of striated muscle. In MYH7 two mutations (Ala223Thr and Ser642Leu) were found in two patients. Ser642Leu is part of the actin-myosin interface. Ala223Thr affects a buried residue near the ATP binding site. In MYBPC3 we found one missense mutation (Asn948Thr) in a male patient. None of the mutations were found in 88 healthy controls and in 136 patients with hypertrophic cardiomyopathy (HCM). Thus mutations in HCM causing genes are not rare in DCM and have potential for functional relevance.

    PMID: 12379228 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read